Immunocore (IMCR) News Today $32.42 -0.14 (-0.43%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Immunocore Holdings plc (IMCR): This Small-Cap Stock Is Ready To ExplodeNovember 19 at 10:09 AM | insidermonkey.comIs Immunocore Holdings plc (IMCR) the Best Immunotherapy Stock to Buy Now?November 19 at 8:24 AM | msn.comImmunocore Holdings plc (NASDAQ:IMCR) Given Consensus Recommendation of "Moderate Buy" by AnalystsImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has earned an average recommendation of "Moderate Buy" from the thirteen research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, three have given a hold rating and nine hNovember 16, 2024 | marketbeat.comCrossmark Global Holdings Inc. Invests $866,000 in Immunocore Holdings plc (NASDAQ:IMCR)Crossmark Global Holdings Inc. bought a new position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 27,803 shares of the company's stock, valueNovember 15, 2024 | marketbeat.comPrincipal Financial Group Inc. Grows Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)Principal Financial Group Inc. grew its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 25.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 546,318 shares of the company's stock after buyiNovember 15, 2024 | marketbeat.comImmunocore Holdings (IMCR) Gets a Buy from J.P. MorganNovember 12, 2024 | markets.businessinsider.comMizuho Downgrades Immunocore Holdings plc - Depositary Receipt () (IMCR)November 12, 2024 | msn.comImmunocore downgraded to Neutral from Outperform at MizuhoNovember 11, 2024 | markets.businessinsider.comMizuho Downgrades Immunocore (NASDAQ:IMCR) to NeutralMizuho lowered Immunocore from an "outperform" rating to a "neutral" rating and reduced their price target for the stock from $72.00 to $38.00 in a report on Monday.November 11, 2024 | marketbeat.comNavigating 8 Analyst Ratings For Immunocore HldgsNovember 11, 2024 | benzinga.com3 Fast-Growing Stocks Analysts See Doubling in Price (IMCR)Clinical-stage biotech firms often have massive upside potential, but much of that possible success hinges on successful trials and product launches.November 11, 2024 | marketbeat.comFY2024 EPS Estimates for Immunocore Lifted by HC WainwrightNovember 11, 2024 | americanbankingnews.comAnalysts Set Expectations for Immunocore FY2024 EarningsImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Investment analysts at HC Wainwright boosted their FY2024 earnings estimates for Immunocore in a research note issued on Thursday, November 7th. HC Wainwright analyst P. Trucchio now anticipates that the company will post earnings per share ofNovember 11, 2024 | marketbeat.comFiera Capital Corp Decreases Position in Immunocore Holdings plc (NASDAQ:IMCR)Fiera Capital Corp lowered its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 3.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 845,732 shares of the company's stock after selling 29,861 sharNovember 9, 2024 | marketbeat.comImmunocore Holdings: Strategic Advancements and Financial Stability Support Buy RatingNovember 8, 2024 | markets.businessinsider.comImmunocore to present at upcoming investor conferencesNovember 8, 2024 | globenewswire.comLeerink Partnrs Raises Earnings Estimates for ImmunocoreImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Equities research analysts at Leerink Partnrs boosted their FY2024 EPS estimates for Immunocore in a research note issued on Wednesday, November 6th. Leerink Partnrs analyst J. Chang now expects that the company will post earnings per share ofNovember 8, 2024 | marketbeat.comImmunocore Hldgs (NASDAQ:IMCR) Stock, Option ChainNovember 7, 2024 | benzinga.comImmunocore Holdings: Strong Buy Rating Backed by Successful KIMMTRAK Launch and Promising Clinical PipelineNovember 7, 2024 | markets.businessinsider.comBarclays Keeps Their Buy Rating on Immunocore Holdings (IMCR)November 7, 2024 | markets.businessinsider.comNeedham & Company LLC Cuts Immunocore (NASDAQ:IMCR) Price Target to $71.00Needham & Company LLC cut their price objective on shares of Immunocore from $78.00 to $71.00 and set a "buy" rating for the company in a report on Thursday.November 7, 2024 | marketbeat.comImmunocore reports third quarter financial results and provides a business updateNovember 6, 2024 | globenewswire.comImmunocore (NASDAQ:IMCR) Stock Price Up 7.4% - Should You Buy?Immunocore (NASDAQ:IMCR) Stock Price Up 7.4% - Here's What HappenedOctober 28, 2024 | marketbeat.comUBS Initiates Coverage of Immunocore Holdings plc - Depositary Receipt () (IMCR) with Sell RecommendationOctober 25, 2024 | msn.comImmunocore initiated with a Sell at UBSOctober 25, 2024 | markets.businessinsider.comUBS launches SMID cap biotechs with cancer, autoimmunity in focusOctober 24, 2024 | seekingalpha.comImmunocore's (IMCR) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $100.00 target price on shares of Immunocore in a research report on Thursday.October 24, 2024 | marketbeat.comUBS Group Initiates Coverage on Immunocore (NASDAQ:IMCR)UBS Group began coverage on shares of Immunocore in a research note on Thursday. They set a "sell" rating and a $24.00 price objective on the stock.October 24, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Immunocore Holdings plc (NASDAQ:IMCR - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the thirteen ratings firms that are covering the company, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and eleven have assigned a buyOctober 22, 2024 | marketbeat.comSG Americas Securities LLC Cuts Stock Position in Immunocore Holdings plc (NASDAQ:IMCR)SG Americas Securities LLC trimmed its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 94.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,800 shares of the company's stock aOctober 21, 2024 | marketbeat.comQ3 EPS Estimates for Immunocore Reduced by AnalystImmunocore Holdings plc (NASDAQ:IMCR - Free Report) - Capital One Financial dropped their Q3 2024 earnings estimates for Immunocore in a report released on Wednesday, October 16th. Capital One Financial analyst N. Quibria now expects that the company will earn ($0.38) per share for the quarter, dOctober 21, 2024 | marketbeat.comIMCR Immunocore Holdings plcOctober 17, 2024 | seekingalpha.comImmunocore Holdings (IMCR) Receives a Buy from Morgan StanleyOctober 12, 2024 | markets.businessinsider.comMorgan Stanley Trims Immunocore (NASDAQ:IMCR) Target Price to $74.00Morgan Stanley reduced their target price on Immunocore from $80.00 to $74.00 and set an "overweight" rating for the company in a research note on Friday.October 11, 2024 | marketbeat.comImmunocore Holdings PLC (IMCR) Q2 2024 Earnings Call Highlights: Strong US Growth and Strategic ...October 10, 2024 | finance.yahoo.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Purchased by The Manufacturers Life Insurance CompanyThe Manufacturers Life Insurance Company increased its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 37.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 121October 8, 2024 | marketbeat.comGuggenheim Downgrades Immunocore Holdings plc - Depositary Receipt () (IMCR)October 8, 2024 | msn.comBuy Rating on Immunocore Holdings Bolstered by KOL Insights and Oncology AdvancementsOctober 7, 2024 | markets.businessinsider.comMillennium Management LLC Acquires 333,167 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Millennium Management LLC lifted its holdings in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 124.4% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 600,954 shares of the company's stock after acquiring an additOctober 5, 2024 | marketbeat.comImmunocore (NASDAQ:IMCR) Reaches New 52-Week Low at $29.72Immunocore (NASDAQ:IMCR) Sets New 1-Year Low at $29.72October 3, 2024 | marketbeat.comSquarepoint Ops LLC Buys 70,648 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Squarepoint Ops LLC grew its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 2,265.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 73,766 shares of the company's stock after acquiring an additional 70,648 shareOctober 3, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Shares Acquired by Marshall Wace LLPMarshall Wace LLP lifted its stake in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 14.1% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 248,654 shares of the company's stock after purchasing an addSeptember 30, 2024 | marketbeat.comImmunocore Holdings plc (IMCR): Worst 52-Week Low Stock to Buy NowSeptember 29, 2024 | msn.comFrazier Life Sciences Management L.P. Purchases New Holdings in Immunocore Holdings plc (NASDAQ:IMCR)Frazier Life Sciences Management L.P. acquired a new position in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 108,762 shares of the company's stock, valued at approximately $3,686,000. FSeptember 29, 2024 | marketbeat.comImmunocore Holdings plc (NASDAQ:IMCR) Ranks Low On The List Of Worst Falling Stocks To BuySeptember 27, 2024 | insidermonkey.comImmunocore Holdings plc (NASDAQ:IMCR) Receives Average Recommendation of "Moderate Buy" from AnalystsImmunocore Holdings plc (NASDAQ:IMCR - Get Free Report) has earned an average rating of "Moderate Buy" from the twelve research firms that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eleven have given a buy recommendatSeptember 27, 2024 | marketbeat.comArmistice Capital LLC Raises Holdings in Immunocore Holdings plc (NASDAQ:IMCR)Armistice Capital LLC lifted its holdings in Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 495.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 976,000 shares of the company's stock after purchasing an addSeptember 26, 2024 | marketbeat.comBarclays Gives a Buy Rating to Immunocore Holdings (IMCR)September 25, 2024 | markets.businessinsider.comImmunocore Holdings plc (IMCR) Hits 52-Week Low Despite 34% Surge in KIMMTRAK SalesSeptember 25, 2024 | finance.yahoo.comRenaissance Technologies LLC Purchases 82,120 Shares of Immunocore Holdings plc (NASDAQ:IMCR)Renaissance Technologies LLC grew its position in shares of Immunocore Holdings plc (NASDAQ:IMCR - Free Report) by 14.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 646,920 shares of the company's stock after purchasingSeptember 21, 2024 | marketbeat.com Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address “Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. IMCR Media Mentions By Week IMCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMCR News Sentiment▼1.420.45▲Average Medical News Sentiment IMCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMCR Articles This Week▼54▲IMCR Articles Average Week Get Immunocore News Delivered to You Automatically Sign up to receive the latest news and ratings for IMCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BPMC News Today LNTH News Today NUVL News Today CYTK News Today VKTX News Today RNA News Today CRNX News Today KRYS News Today ADMA News Today TGTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMCR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunocore Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Immunocore With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IMCR Stock Alerts